User profiles for Richard O. Phillips

Richard Odame Phillips

Professor of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi …
Verified email at knust.edu.gh
Cited by 8744

Prevalence, detection, management, and control of hypertension in Ashanti, West Africa

…, SM Kerry, S Antwi, R Martin-Peprah, RO Phillips… - …, 2004 - Am Heart Assoc
Hypertension and stroke are important threats to the health of adults in sub-Saharan Africa.
Nevertheless, detection of hypertension is haphazard and stroke prevention targets are …

[HTML][HTML] Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority …

RO Phillips, J Robert, KM Abass, W Thompson… - The Lancet, 2020 - thelancet.com
Background Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans
infection that damages the skin and subcutis. It is most prevalent in western and central …

[HTML][HTML] Genetic diversity of SARS-CoV-2 infections in Ghana from 2020-2021

…, S Dassah, V Asoala, KP Asante, RO Phillips… - Nature …, 2022 - nature.com
The COVID-19 pandemic is one of the fastest evolving pandemics in recent history. As such,
the SARS-CoV-2 viral evolution needs to be continuously tracked. This study sequenced …

[HTML][HTML] Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial

S Klis, Y Stienstra, RO Phillips, KM Abass… - PLoS Neglected …, 2014 - journals.plos.org
Background Buruli Ulcer (BU) is a tropical infectious skin disease that is currently treated
with 8 weeks of intramuscular streptomycin and oral rifampicin. As prolonged streptomycin …

[HTML][HTML] Mycolactone diffuses into the peripheral blood of buruli ulcer patients-implications for diagnosis and disease monitoring

…, F Le Chevalier, NG Aka, RO Phillips… - PLoS neglected …, 2011 - journals.plos.org
Background Mycobacterium ulcerans, the causative agent of Buruli ulcer (BU), is unique
among human pathogens in its capacity to produce a polyketide-derived macrolide called …

[HTML][HTML] Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection

…, A Sylverken, M Owusu, RO Phillips - PLoS …, 2021 - journals.plos.org
Introduction Coronavirus disease-19 (COVID-19), which started in late December, 2019,
has spread to affect 216 countries and territories around the world. Globally, the number of …

Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of …

RO Phillips, FS Sarfo, MK Abass, J Abotsi… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Buruli ulcer, an ulcerating skin disease caused by Mycobacterium ulcerans infection, is
common in tropical areas of western Africa. We determined the clinical and microbiological …

[HTML][HTML] Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease

FS Sarfo, RO Phillips, J Zhang, MK Abass… - BMC infectious …, 2014 - Springer
Background Mycobacterium ulcerans (M. ulcerans) causes a devastating necrotising infection
of skin tissue leading to progressive ulceration. M. ulcerans is the only human pathogen …

[HTML][HTML] High prevalence of asymptomatic malaria infections in adults, Ashanti Region, Ghana, 2018

M Heinemann, RO Phillips, CD Vinnemeier, CC Rolling… - Malaria journal, 2020 - Springer
Background Ghana is among the high-burden countries for malaria infections and recently
reported a notable increase in malaria cases. While asymptomatic parasitaemia is …

[HTML][HTML] Detection of Mycolactone A/B in Mycobacterium ulcerans–Infected Human Tissue

FS Sarfo, RO Phillips, B Rangers… - PLoS neglected …, 2010 - journals.plos.org
Background Mycobacterium ulcerans disease (Buruli ulcer) is a neglected tropical disease
common amongst children in rural West Africa. Animal experiments have shown that tissue …